Brief: Lansen Pharmaceutical Says HY Profit Attributable $6.8 Mln
31/08/2022 13:55
Aug 31 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* HY PROFIT ATTRIBUTABLE US$6.8 MILLION VERSUS US$1.5
MILLION
* HY REVENUE $32 MILLION VERSUS $23.5 MILLION
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year